Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment

R. Hobzova, J. Sirc, K. Shrestha, B. Mudrova, Z. Bosakova, M. Slouf, M. Munzarova, J. Hrabeta, T. Feglarova, AI. Cocarta

. 2023 ; 15 (5) : . [pub] 20230503

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009839

Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009839
003      
CZ-PrNML
005      
20230721095435.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics15051398 $2 doi
035    __
$a (PubMed)37242640
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hobzova, Radka $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 https://orcid.org/0000000268688046
245    10
$a Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment / $c R. Hobzova, J. Sirc, K. Shrestha, B. Mudrova, Z. Bosakova, M. Slouf, M. Munzarova, J. Hrabeta, T. Feglarova, AI. Cocarta
520    9_
$a Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sirc, Jakub $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
700    1_
$a Shrestha, Kusum $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
700    1_
$a Mudrova, Barbora $u Department of Analytical Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic
700    1_
$a Bosakova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic $1 https://orcid.org/0000000284835739 $7 jo2005273839
700    1_
$a Slouf, Miroslav $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 https://orcid.org/000000031528802X $7 xx0107048
700    1_
$a Munzarova, Marcela $u Nanomedical Co., Ltd., 463 12 Liberec, Czech Republic
700    1_
$a Hrabeta, Jan $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic
700    1_
$a Feglarova, Tereza $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic
700    1_
$a Cocarta, Ana-Irina $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 15, č. 5 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37242640 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095428 $b ABA008
999    __
$a ok $b bmc $g 1958525 $s 1196103
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 5 $e 20230503 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...